Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: A Pediatric Brain Tumor Consortium report1

Authors:
  • RJRegina I. Jakacki
    Regina I. Jakacki
  • SBSusan M. Blaney
    Susan M. Blaney
  • MHMichael L. Hancock
    Michael L. Hancock
  • PPPeter Phillips
    Peter Phillips
  • LKLarry E. Kun
    Larry E. Kun
  • HFHenry Friedman
    Henry Friedman
  • RPRoger Packer
    Roger Packer
  • ABAnu Banerjee
    Anu Banerjee
  • JGJ. Russell Geyer
    J. Russell Geyer
  • SGStewart Goldman
    Stewart Goldman

Abstract
This study estimated the maximum tolerated dose (MTD) of imatinib with irradiation in children with newly diagnosed brainstem gliomas, and those with

This publication has 49 references indexed in Scilit: